During the past decade, Fundação Faculdade Regional de Medicina de São José do Rio Preto conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 19 clinical trials were completed, i.e. on average, 35.8% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 14 clinical trials were completed. i.e. 48.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundação Faculdade Regional de Medicina de São José do Rio Preto" #1 sponsor was "Pfizer" with 6 trials, followed by "Butantan Institute" with 4 trials sponsored, "Hospital Israelita Albert Einstein" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundação Faculdade Regional de Medicina de São José do Rio Preto" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "CytoDyn, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Bayer AG (Sponsor)" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Fundação Faculdade Regional de Medicina de São José do Rio Preto" are "COVID-19" (3 trials), "Covid19" (3 trials), "COVID-19 Pneumonia" (2 trials), "Cardiovascular Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Fundação Faculdade Regional de Medicina de São José do Rio Preto" in a lesser frequency.

Most popular intervention types in "Fundação Faculdade Regional de Medicina de São José do Rio Preto" are "Drug" (53 trials), "Biological" (8 trials), "Other" (8 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Avelumab" (4 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fundação Faculdade Regional de Medicina de São José do Rio Preto" are 59 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fundação Faculdade Regional de Medicina de São José do Rio Preto". undefined are not yet recruiting, 13 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Fundação Faculdade Regional de Medicina de São José do Rio Preto, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Fundação Faculdade Regional de Medicina de São José do Rio Preto, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".